Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/9283
Title: | Correlation between antibiotic consumption and resistance of Pseudomonas aeruginosa in a teaching hospital implementing an antimicrobial stewardship program: A longitudinal observational study |
Authors: | Huang, Hsiao-Wen Liu, Hsin-Yi Chuang, Han-Chuan Chen, Bi-Li Wang, Er-Ying Tsao, Li-Hsin |
Keywords: | Antimicrobial stewardship programs (ASPs) Pseudomonas aeruginosa (P. aeruginosa) Resistance Antibiotics consumption Extended-infusion therapy |
Issue Date: | Apr-2023 |
Publisher: | Elsevier Taiwan LLC |
Citation: | Original Article |
Abstract: | Abstract Background/purpose: The rapid emergence of Pseudomonas aeruginosa resistance made selecting antibiotics more challenge. Antimicrobial stewardship programs (ASPs) are urging to implant to control the P. aeruginosa resistance. The purpose of this study is to evaluate the relationship between antimicrobial consumption and P. aeruginosa resistance, the impact of ASPs implemented during the 14-year study period. Methods: A total 14,852 P. aeruginosa isolates were included in our study. The resistant rate and antimicrobial consumption were investigated every six months. Linear regression analysis was conducted to examine the trends in antibiotics consumption and antimicrobial resistance over time. The relationship between P. aeruginosa resistance and antimicrobial consumption were using Pearson correlation coefficient to analysis. The trend of resistance before and after ASPs implanted is evaluated by segment regression analysis. Results: P. aeruginosa resistance to ceftazidime, gentamicin, amikacin, ciprofloxacin and levofloxacin significantly decreased during the study period; piperacillin/tazobactam (PTZ), cefepime, imipenem/cilastatin and meropenem remained stable. The P. aeruginosa resistance to ciprofloxacin and levofloxacin increasing initial then decreased after strictly controlled the use of levofloxacin since 2007. As the first choice antibiotic to treat P. aeruginosa, the consumption and resistance to PTZ increase yearly and resistance became stable since extended-infusion therapy policy implant in 2009. Conclusion: Our ASP intervention strategy, which included extended infusion of PTZ and restrict use of levofloxacin, may be used to control antimicrobial resistance of P. aeruginosa in medical practice. |
URI: | http://localhost:8080/xmlui/handle/123456789/9283 |
Appears in Collections: | VOL 56 NO 2 2023 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
337-343.pdf | 505.67 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.